CVS HEALTH CORPORATION Policyholder Benefits and Claims Incurred, Net
CVS HEALTH CORPORATION (CVS) reported Policyholder Benefits and Claims Incurred, Net of $31.48 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PolicyholderBenefitsAndClaimsIncurredNet · last filed 2026-08-05
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, net for the quarter ending 2026-06-30 was $31.48B, a 0.54% increase year-over-year.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, net for the quarter ending 2026-03-31 was $29.36B, a 0.77% increase year-over-year.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, net for the quarter ending 2025-12-31 was $33.07B, a 11.92% increase year-over-year.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, net for the quarter ending 2025-09-30 was $32.02B, a 7.01% increase year-over-year.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, net for fiscal 2025 was $125.54B, a 9.05% increase from fiscal 2024.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, net for fiscal 2024 was $115.12B, a 33.48% increase from fiscal 2023.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, net for fiscal 2023 was $86.25B, a 21.35% increase from fiscal 2022.
- CVS HEALTH CORPORATION policyholder benefits and claims incurred, net for fiscal 2022 was $71.07B, a 10.73% increase from fiscal 2021.
| Period end | Policyholder Benefits and Claims Incurred, Net 3 month | Policyholder Benefits and Claims Incurred, Net 6 month | Policyholder Benefits and Claims Incurred, Net 9 month | Policyholder Benefits and Claims Incurred, Net 12 month | Policyholder Benefits and Claims Incurred, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $31.48B 10-Q · filed 2026-08-05 | $60.84B 10-Q · filed 2026-08-05 | $93.91B derived: sum of 3 quarters · filed 2026-08-05 | $125.93B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $29.36B 10-Q · filed 2026-05-06 | $62.42B derived: sum of 2 quarters · filed 2026-05-06 | $94.44B derived: sum of 3 quarters · filed 2026-05-06 | $125.76B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $33.07B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $65.09B derived: sum of 2 quarters · filed 2026-02-10 | $96.40B derived: sum of 3 quarters · filed 2026-08-05 | $125.54B 10-K · filed 2026-02-10 | |
| 2025-09-30 | $32.02B 10-Q · filed 2025-10-29 | $63.34B derived: sum of 2 quarters · filed 2026-08-05 | $92.47B 10-Q · filed 2025-10-29 | $122.02B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $31.32B 10-Q · filed 2026-08-05 | $60.45B 10-Q · filed 2026-08-05 | $90.00B derived: sum of 3 quarters · filed 2026-08-05 | $119.92B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $29.14B 10-Q · filed 2026-05-06 | $58.68B derived: sum of 2 quarters · filed 2026-05-06 | $88.60B derived: sum of 3 quarters · filed 2026-05-06 | $116.45B derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $29.54B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $59.47B derived: sum of 2 quarters · filed 2026-02-10 | $87.32B derived: sum of 3 quarters · filed 2026-02-10 | $115.12B 10-K · filed 2026-02-10 | |
| 2024-09-30 | $29.92B 10-Q · filed 2025-10-29 | $57.77B derived: sum of 2 quarters · filed 2025-10-29 | $85.58B 10-Q · filed 2025-10-29 | $108.10B derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-06-30 | $27.85B 10-Q · filed 2025-07-31 | $55.66B 10-Q · filed 2025-07-31 | $78.17B derived: sum of 3 quarters · filed 2026-02-10 | $99.67B derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-03-31 | $27.80B 10-Q · filed 2025-05-01 | $50.32B derived: sum of 2 quarters · filed 2026-02-10 | $71.82B derived: sum of 3 quarters · filed 2026-02-10 | $93.60B derived: sum of 4 quarters · filed 2026-02-10 | |
| 2023-12-31 | $22.52B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $44.02B derived: sum of 2 quarters · filed 2026-02-10 | $65.80B derived: sum of 3 quarters · filed 2026-02-10 | $86.25B 10-K · filed 2026-02-10 | |
| 2023-09-30 | $21.50B 10-Q · filed 2024-11-06 | $43.28B derived: sum of 2 quarters · filed 2024-11-06 | $63.73B 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $21.78B 10-Q · filed 2024-08-07 | $42.23B 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $71.07B 10-K · filed 2025-02-12 | $71.28B 10-K · filed 2023-02-08 | |||
| 2021-12-31 | $64.19B 10-K · filed 2024-02-07 | $64.26B 10-K · filed 2022-02-09 | |||
| 2020-12-31 | $55.68B 8-K · filed 2023-05-25 | ||||
| 2019-12-31 | $52.53B 10-K · filed 2022-02-09 | ||||
| 2018-12-31 | $6.59B 10-K · filed 2021-02-16 | ||||
| 2018-06-30 | $6.59B 8-K · filed 2019-08-08 | ||||
| 2017-12-31 | $2.81B 8-K · filed 2019-08-08 | ||||
| 2016-12-31 | $2.18B 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |